STOCK TITAN

[Form 4] Simulations Plus, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Simulations Plus director Lisa LaVange reported the sale of 867 shares of the company's common stock on 09/02/2025. The Form 4 states the shares were sold in a single transaction at $14.10 per share and that the sale was effected automatically pursuant to a Rule 10b5-1 trading plan. Following the reported transaction, Ms. LaVange beneficially owns 9,063 shares and holds those shares in a direct ownership form. The filing indicates the reporter is a director and the Form 4 was executed by an attorney-in-fact on 09/04/2025.

La direttrice di Simulations Plus, Lisa LaVange, ha comunicato la vendita di 867 azioni dell'azione ordinaria della società il 02/09/2025. Il Modulo 4 indica che le azioni sono state cedute in un'unica operazione a $14,10 per azione e che la vendita è stata eseguita automaticamente ai sensi di un piano di negoziazione ai sensi della Regola 10b5-1. A seguito della transazione comunicata, la signora LaVange detiene la titolarità economica di 9.063 azioni e le possiede in forma di proprietà diretta. La comunicazione specifica che la dichiarante è una direttrice e che il Modulo 4 è stato firmato da un procuratore il 04/09/2025.

Lisa LaVange, miembro del consejo de Simulations Plus, informó la venta de 867 acciones ordinarias de la compañía el 02/09/2025. El Formulario 4 señala que las acciones se vendieron en una sola transacción a $14,10 por acción y que la venta se efectuó automáticamente conforme a un plan de negociación establecido bajo la Norma 10b5-1. Tras la operación comunicada, la Sra. LaVange posee beneficiosamente 9.063 acciones y las mantiene en propiedad directa. El informe indica que la informante es directora y que el Formulario 4 fue firmado por un apoderado el 04/09/2025.

Simulations Plus 이사인 Lisa LaVange가 2025년 9월 2일 회사 보통주 867주를 매도했다고 보고했습니다. Form 4에는 해당 주식이 주당 $14.10에 단일 거래로 매도되었으며, 매도는 Rule 10b5-1 거래계획에 따라 자동으로 이루어졌다고 기재되어 있습니다. 보고된 거래 이후 LaVange 씨는 실질적으로 9,063주를 보유하고 있으며, 해당 주식은 직접 소유 형태로 보유하고 있습니다. 서류에는 보고자가 이사임을 명시하고 있으며 Form 4는 2025년 9월 4일에 대리인이 서명해 제출되었다고 기재되어 있습니다.

Lisa LaVange, administratrice de Simulations Plus, a déclaré la vente de 867 actions ordinaires de la société le 02/09/2025. Le formulaire 4 précise que les actions ont été vendues en une seule opération à 14,10 $ par action et que la vente a été effectuée automatiquement en vertu d'un plan de négociation conforme à la règle 10b5-1. À la suite de la transaction déclarée, Mme LaVange détient indirectement 9 063 actions et les possède en propriété directe. Le dépôt indique que la déclarante est administratrice et que le formulaire 4 a été signé par un mandataire le 04/09/2025.

Lisa LaVange, Direktorin von Simulations Plus, meldete den Verkauf von 867 Anteilen der Stammaktien des Unternehmens am 02.09.2025. Im Formular 4 heißt es, die Aktien seien in einer einzigen Transaktion zu $14,10 pro Aktie veräußert worden und der Verkauf sei automatisch im Rahmen eines Rule-10b5-1-Handelsplans ausgeführt worden. Nach der gemeldeten Transaktion besitzt Frau LaVange wirtschaftlich 9.063 Aktien und hält diese in direktem Eigentum. Die Einreichung weist zudem aus, dass die Meldende eine Direktorin ist und das Formular 4 am 04.09.2025 von einem Bevollmächtigten unterzeichnet wurde.

Positive
  • Transaction disclosed as executed under a Rule 10b5-1 plan, indicating a prearranged trade and transparency
  • Full transaction details provided including date, number of shares, and sale price ($14.10)
Negative
  • Insider sale of 867 shares reduces the director's holding to 9,063 shares
  • No information on total outstanding shares or percentage ownership is provided in this filing, limiting assessment of materiality

Insights

TL;DR: Director sold 867 shares under a 10b5-1 plan at $14.10, leaving 9,063 shares beneficially owned.

The reported transaction is explicitly labeled as executed under a Rule 10b5-1 plan, which signals a prearranged sale rather than opportunistic trading. The sale price of $14.10 and the quantity of 867 shares are disclosed, and the remaining beneficial ownership is reported as 9,063 shares. From a shareholder perspective, this filing provides transparent disclosure of an insider disposition but contains no further financial metrics or change in control indicators.

TL;DR: Disclosure shows compliance with Section 16 and use of a 10b5-1 plan; filing appears procedurally complete.

The Form 4 lists the reporting person as a director and marks the transaction as pursuant to a 10b5-1 plan, which helps establish the affirmative defense to insider trading claims. The form reports direct ownership and provides the transaction date and execution details. The signature was provided by an attorney-in-fact, which is permitted and noted on the form. No amendments or additional arrangements are disclosed.

La direttrice di Simulations Plus, Lisa LaVange, ha comunicato la vendita di 867 azioni dell'azione ordinaria della società il 02/09/2025. Il Modulo 4 indica che le azioni sono state cedute in un'unica operazione a $14,10 per azione e che la vendita è stata eseguita automaticamente ai sensi di un piano di negoziazione ai sensi della Regola 10b5-1. A seguito della transazione comunicata, la signora LaVange detiene la titolarità economica di 9.063 azioni e le possiede in forma di proprietà diretta. La comunicazione specifica che la dichiarante è una direttrice e che il Modulo 4 è stato firmato da un procuratore il 04/09/2025.

Lisa LaVange, miembro del consejo de Simulations Plus, informó la venta de 867 acciones ordinarias de la compañía el 02/09/2025. El Formulario 4 señala que las acciones se vendieron en una sola transacción a $14,10 por acción y que la venta se efectuó automáticamente conforme a un plan de negociación establecido bajo la Norma 10b5-1. Tras la operación comunicada, la Sra. LaVange posee beneficiosamente 9.063 acciones y las mantiene en propiedad directa. El informe indica que la informante es directora y que el Formulario 4 fue firmado por un apoderado el 04/09/2025.

Simulations Plus 이사인 Lisa LaVange가 2025년 9월 2일 회사 보통주 867주를 매도했다고 보고했습니다. Form 4에는 해당 주식이 주당 $14.10에 단일 거래로 매도되었으며, 매도는 Rule 10b5-1 거래계획에 따라 자동으로 이루어졌다고 기재되어 있습니다. 보고된 거래 이후 LaVange 씨는 실질적으로 9,063주를 보유하고 있으며, 해당 주식은 직접 소유 형태로 보유하고 있습니다. 서류에는 보고자가 이사임을 명시하고 있으며 Form 4는 2025년 9월 4일에 대리인이 서명해 제출되었다고 기재되어 있습니다.

Lisa LaVange, administratrice de Simulations Plus, a déclaré la vente de 867 actions ordinaires de la société le 02/09/2025. Le formulaire 4 précise que les actions ont été vendues en une seule opération à 14,10 $ par action et que la vente a été effectuée automatiquement en vertu d'un plan de négociation conforme à la règle 10b5-1. À la suite de la transaction déclarée, Mme LaVange détient indirectement 9 063 actions et les possède en propriété directe. Le dépôt indique que la déclarante est administratrice et que le formulaire 4 a été signé par un mandataire le 04/09/2025.

Lisa LaVange, Direktorin von Simulations Plus, meldete den Verkauf von 867 Anteilen der Stammaktien des Unternehmens am 02.09.2025. Im Formular 4 heißt es, die Aktien seien in einer einzigen Transaktion zu $14,10 pro Aktie veräußert worden und der Verkauf sei automatisch im Rahmen eines Rule-10b5-1-Handelsplans ausgeführt worden. Nach der gemeldeten Transaktion besitzt Frau LaVange wirtschaftlich 9.063 Aktien und hält diese in direktem Eigentum. Die Einreichung weist zudem aus, dass die Meldende eine Direktorin ist und das Formular 4 am 04.09.2025 von einem Bevollmächtigten unterzeichnet wurde.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
LaVange Lisa

(Last) (First) (Middle)
800 PARK OFFICES DRIVE
SUITE 401

(Street)
RESEARCH TRIANGLE PARK NC 27709

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Simulations Plus, Inc. [ SLP ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
09/02/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/02/2025 S(1) 867 D $14.1(2) 9,063 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The sales reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person.
2. These shares were sold in a single transaction at $14.10.
Remarks:
/s/ William Frederick, attorney-in-fact for Lisa LaVange 09/04/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Simulations Plus director Lisa LaVange report on Form 4 (SLP)?

The Form 4 reports a sale of 867 shares of Simulations Plus common stock on 09/02/2025 at $14.10 per share.

Was the sale by Lisa LaVange part of a 10b5-1 plan?

Yes. The filing states the sales were effected automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person.

How many Simulations Plus shares does Lisa LaVange beneficially own after the sale?

The Form 4 reports that Ms. LaVange beneficially owns 9,063 shares following the transaction.

What was the sale price reported on the Form 4 for SLP?

The shares were sold in a single transaction at a price of $14.10 per share.

Who signed the Form 4 for Lisa LaVange and when?

The Form 4 was signed by William Frederick, attorney-in-fact for Lisa LaVange on 09/04/2025.
Simulations Plus Inc

NASDAQ:SLP

SLP Rankings

SLP Latest News

SLP Latest SEC Filings

SLP Stock Data

284.19M
16.63M
17.38%
85.96%
8.15%
Health Information Services
Services-computer Integrated Systems Design
Link
United States
RESEARCH TRIANGLE PARK